L. Moser

发表

Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer—a review focusing on open questions

W. Hinkelbein, J. Ritz, L. Moser, 2008, International Journal of Colorectal Disease.

Radiotherapy in biochemical recurrences after surgery for prostate cancer.

W. Hinkelbein, L. Moser, S. Höcht, 2008, Frontiers of radiation therapy and oncology.

Locally recurrent colorectal cancer: results of surgical therapy

J. Budczies, H. Buhr, J. Gröne, 2012, Langenbeck's Archives of Surgery.

Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.

T. Kühn, R. Kreienberg, L. Moser, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Impact of neoadjuvant chemoradiation therapy on the postoperative complication rate in rectal cancer

H. Buhr, J. Gröne, S. Daum, 2014 .

Histopathological regression grading matches excellently with local and regional spread after neoadjuvant therapy of rectal cancer.

M. Dietel, J. Budczies, H. Buhr, 2013, Pathology, research and practice.

Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study.

A. Ng, L. Specht, R. Tsang, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Intrasplenic Pancreatic Pseudocyst after Chemoradiation of a Pancreatic Adenocarcinoma Mimicking Progressive Disease: A Case Report and Review of the Literature

P. Kiewe, I. Platzek, M. Schuler, 2019, Case reports in oncological medicine.

Proton beam therapy of parapapillary choroidal melanoma.

D. Cordini, A. Joussen, A. Riechardt, 2014, American journal of ophthalmology.

Proton beam therapy leads to excellent local control rates in choroidal melanoma in the intermediate fundus zone.

D. Cordini, A. Joussen, A. Riechardt, 2014, American journal of ophthalmology.

Neoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 cases

D. Cordini, M. Foerster, N. Bechrakis, 2015, British Journal of Ophthalmology.

Salvage proton beam therapy in local recurrent uveal melanoma.

D. Cordini, A. Joussen, A. Riechardt, 2014, American journal of ophthalmology.

Long-term results after proton beam therapy for retinal papillary capillary hemangioma.

D. Cordini, A. Joussen, A. Riechardt, 2014, American journal of ophthalmology.

Proton beam radiotherapy of diffuse iris melanoma in 54 patients

D. Cordini, A. Joussen, M. Foerster, 2014, British Journal of Ophthalmology.

Diagnostik und Therapie choroidaler Melanome

A. Joussen, A. Riechardt, S. Türkmen, 2013, Klin Monatsbl Augenheilkd.

[Treatment modalities for conjunctival melanoma].

T. Plath, M. Foerster, N. Bechrakis, 2009, Klinische Monatsblatter fur Augenheilkunde.

Interdisciplinary decision making in prostate cancer therapy – 5-years’ time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin

Martin Schostak, Thomas Wiegel, Stefan Höcht, 2013, BMC Medical Informatics and Decision Making.

Long-term (4 years) results of choroidal hemangioma treated with proton beam irradiation

D. Cordini, A. Joussen, L. Moser, 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

Proton beam radiotherapy of progressive pediatric choroidal osteoma: first experience.

M. Foerster, E. Altpeter, S. Aisenbrey, 2014, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

Multimodale palliative Behandlung des Pankreaskarzinoms

V. Budach, L. Moser, H. Oettle, 2004, Der Onkologe.

Hormone-refractory and metastatic prostate cancer - palliative radiotherapy.

W. Hinkelbein, T. Schubert, L. Moser, 2008, Frontiers of radiation therapy and oncology.

Virtual Simulation of a Boost Field in Adjuvant Radiotherapy of the Breast

Lutz Moser, Volker Budach, M. Hinkelbein, 2004, Strahlentherapie und Onkologie.

Mitomycin-C and 5-Fluoro-Uracil Containing Chemotherapy With Concurrent Hyperfractionated Accelerated RadioTherapy (C-HART) of 70.6 Gy Is More Effective than Dose Escalated HART of 77.6 Gy Alone–10 Year Results of the German Multicenter Phase III Randomized Trial (ARO 95-06)

P. Wust, V. Budach, K. Wernecke, 2007 .

Five years' results of the German ARO 04-01 trial of concurrent 72 Gy hyperfractionated accelerated radiation therapy (HART) plus once weekly cisplatinum/5-FU versus mitomycin C/5-FU in stage IV head and neck cancer.

V. Budach, H. Iro, J. Werner, 2012 .